Response to Immune Checkpoint Inhibitor Therapy in Patients with Unresectable Recurrent Malignant Pleural Mesothelioma Shown by FDG-PET and CT

SIMPLE SUMMARY: This is the first known study to compare three FDG-PET/CT criteria (EORTC, PERCIST, imPERCIST) with CT criteria (combined modified RECIST and RECIST 1.1) used to evaluate tumor response to ICI therapy in patients with recurrent MPM as well as prediction of prognosis. All of the FDG-P...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitajima, Kazuhiro, Maruyama, Mitsunari, Yokoyama, Hiroyuki, Minami, Toshiyuki, Yokoi, Takashi, Nakamura, Akifumi, Hashimoto, Masaki, Kondo, Nobuyuki, Kuribayashi, Kozo, Kijima, Takashi, Hasegawa, Seiki, Yamakado, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961728/
https://www.ncbi.nlm.nih.gov/pubmed/33806464
http://dx.doi.org/10.3390/cancers13051098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961728/
https://www.ncbi.nlm.nih.gov/pubmed/33806464
http://dx.doi.org/10.3390/cancers13051098

Ejemplares similares